Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Autoimmune Disorders01:29

Autoimmune Disorders

398
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
398
T Cell Types and Functions01:24

T Cell Types and Functions

963
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
963
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

67.9K
Overview
67.9K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

692
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
692
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blurring the Lines: NPM1 Mutation in Blast Phase CML Challenges Traditional Paradigms.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026
Same author

Therapy-related B-cell acute lymphoblastic leukemia after treatment for multiple myeloma.

American journal of blood research·2026
Same author

Management of Polyarticular Course Juvenile Idiopathic Arthritis and Temporomandibular Joint Arthritis: A Systematic Literature Review and Meta-Analysis Informing the APLAR Consensus Recommendations.

International journal of rheumatic diseases·2026
Same author

The Asia-Pacific League of Associations for Rheumatology Consensus Recommendations on the Management of Juvenile Idiopathic Arthritis (JIA): Polyarticular Course JIA, Temporomandibular Joint Arthritis, Imaging, and Non-Pharmacologic Therapies.

International journal of rheumatic diseases·2026
Same author

Predictive value for intravenous immunoglobulin resistance of Kobayashi and Kawanet scores in 722 children with Kawasaki disease across diverse ethnic backgrounds (KIWI study): an international cohort study.

EClinicalMedicine·2026
Same author

Disease Damage in Juvenile Idiopathic Arthritis: Authors' Reply.

Indian journal of pediatrics·2026

Related Experiment Video

Updated: Jun 15, 2025

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

1.2K

CAR T-Cell Therapy: A Promising Modality for Autoimmune Diseases.

Deepshi Thakral1, Tejas Ramanan2, Narendra Kumar Bagri3

  • 1Laboratory Oncology Unit, Dr BRAIRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India.

Indian Pediatrics
|August 28, 2024
PubMed
Summary
This summary is machine-generated.

Chimeric Antigen Receptor (CAR) T-cell therapy shows promise beyond blood cancers. This review explores its potential for treating severe autoimmune and inflammatory diseases resistant to standard treatments.

More Related Videos

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

7.9K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

14.9K

Related Experiment Videos

Last Updated: Jun 15, 2025

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

1.2K
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

7.9K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

14.9K

Area of Science:

  • Immunology
  • Cellular Therapy
  • Autoimmune Diseases

Background:

  • Chimeric Antigen Receptor (CAR) T-cells are a novel immunotherapy.
  • CAR T-cells are approved for hematological malignancies.
  • This therapy offers a new approach to immune-mediated disorders.

Purpose of the Study:

  • To review the potential of CAR T-cell therapy in autoimmune diseases.
  • To explore applications in immune-mediated inflammatory disorders.
  • To discuss CAR T-cells for conditions refractory to existing treatments.

Main Methods:

  • Literature review of CAR T-cell therapy.
  • Analysis of current research in autoimmune and inflammatory diseases.
  • Discussion of therapeutic scope and challenges.

Main Results:

  • CAR T-cells demonstrate potential for treating autoimmune diseases.
  • This approach may benefit patients with refractory conditions.
  • Further research is needed to establish efficacy and safety.

Conclusions:

  • CAR T-cell therapy holds promise for systemic autoimmune diseases.
  • It represents a potential therapeutic option for refractory immune-mediated disorders.
  • Clinical investigation is warranted to validate its use.